A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to follow up patients who have achieved complete clearance of AK
lesions at the Day 57 visit having completed the PEP005-016 or PEP005-025 studies over a 12
month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety
in the selected treatment area.